Global Health News: Major Updates on Mpox, COVID-19, Polio, and Oropouche Virus

This health news summary covers Nigeria's mpox vaccination, FDA's authorization of Novavax's updated COVID vaccine, UNICEF's emergency mpox tender, and fake cows at Michigan's state fairs. It also includes Emergent Bio's smallpox vaccine approval, a $300 million opioid settlement, polio vaccinations in Gaza, Oropouche virus spread in Cuba, and new findings on women’s cardio risks.


Devdiscourse News Desk | Updated: 01-09-2024 18:28 IST | Created: 01-09-2024 18:28 IST
Global Health News: Major Updates on Mpox, COVID-19, Polio, and Oropouche Virus
This image is AI-generated and does not depict any real-life event or location. It is a fictional representation created for illustrative purposes only.

Nigeria is set to commence mpox vaccinations from October 8 following regulatory approvals, with the country receiving 10,000 doses from the U.S. Agency for International Development. So far, Nigeria has reported 40 mpox cases without any fatalities.

The FDA has granted emergency use authorization for Novavax's updated COVID-19 vaccine targeting the JN.1 strain, now approved for individuals aged 12 and older.

In collaboration with Gavi, Africa CDC, and WHO, UNICEF has issued an emergency tender to secure mpox vaccines for crisis-hit regions, potentially securing up to 12 million doses through 2025.

Michigan's state fairs will feature life-sized fiberglass cows for milking demos as a precaution against bird flu, with the threat impacting dairy workers and herds.

The FDA has approved Emergent BioSolutions' smallpox vaccine for high-risk mpox infection individuals, marking the second approved mpox shot in the U.S.

A $300 million settlement has been reached between the top U.S. drug distributors and health plans over claims related to the opioid crisis, pending federal court approval.

The UN, alongside Palestinian health authorities, has launched a polio vaccination campaign in Gaza, targeting 640,000 children, amidst ongoing conflict.

Cuba faces challenges combating the Oropouche virus, with over 500 cases reported despite fumigation efforts hindered by fuel shortages and weather conditions.

A new study suggests evaluating women's cardiovascular risks from their 30s, using blood tests to estimate long-term health risks and necessitate early preventive measures.

(With inputs from agencies.)

Give Feedback